SAT-474 Giant Prolactinoma Case Series Assessing Response on Initial Dose of Cabergoline

Background: Giant prolactinomas (GPs) are rare representing 2-3% of prolactinomas and only ~ 0.5% of all pituitary tumors. Various definitions have been proposed for GP but commonly accepted criteria is tumor dimension of ≥4 cm. GP is often associated with very high prolactin (PRL) ranging 1,000 -10...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Endocr Soc
Auteurs principaux: Madan Paramasivan, Ameena, Marouf, Sarah, Raghunathan, Sapna, Shoakazemi, Alireza, Pollock, Jonathan, Chawda, Sanjiv, Stojanovic, Nemanja, Drincic, Andjela
Format: Artigo
Langue:Inglês
Publié: Endocrine Society 2019
Sujets:
Neuroendocrinology and Pituitary
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552231/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-474
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires